Similarly, the high expression of PD-L1 facilitated HSCC cell escape from recognition by the host immune system and accelerated tumor metastasis [12,13], indicating that PD-L1 inhibition may have positive effects on HSCC treatment. This evidence concerns the gene CD274 and neoplasm.